Oxistat cream and lotion deliver:
- Broad approved tinea coverage1-4
- Proven efficacy for tinea pedis, tinea corporis, tinea cruris and tinea versicolor*1,5,6,7
- Once-to-twice daily application1
- No age limitations1
- Available in cream and lotion
* OXISTAT CREAM is indicated for the tinea versicolor due to Malassezia furfur.
For more information, visit Oxistat.com
Important Selected Product Safety Information
Do not use OXISTAT® Cream and Lotion if you have hypersensitivity to any ingredient of this product.
Use the product only externally. OXISTAT is not to be used in the eyes or vagina. Avoid contact with the eyes, nose, mouth, and other mucous membranes. Do not cover the treated area unless directed otherwise by your physician.
Use the medication for the full treatment time recommended by your physician, even though symptoms may have improved.
Inform the physician if the area of application shows signs of increased irritation, itching, burning, blistering, swelling, or oozing. In clinical studies with OXISTAT, the most commonly reported side effects were itching and burning.
If you are pregnant or nursing a baby, consult with physician prior to using this product. For more information, consult your healthcare provider.
Please see the link to the Full Prescribing Information below.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088
- OXISTAT® Cream, OXISTAT® Lotion [prescribing information]. Melville, NY: PharmaDerm, a division of Fougera Pharmaceuticals Inc; 2008.
- Loprox® Gel [prescribing information]. Scottsdale, AZ: MEDICIS, the Dermatology Company®; 2002.
- Naftin® [prescribing information]. Greensboro, NC: Merz Pharmaceuticals; 2004.
- Ertaczo® [prescribing information]. Skillman, NJ: OrthoNeutrogena, a division of Ortho-McNeil Pharmaceutical, Inc; Revised November 2005.
- Ellis CN, Gammon WR, Goldfarb MT, et al. A placebo-controlled evaluation of once-daily versus twice-daily oxiconazole nitrate (1%) cream in the treatment of tinea pedis. Curr Ther Res. 1989;46:269-276.
- Data on file, PharmaDerm.
- Jegasothy BV, Pakes GE. Oxiconazole nitrate: pharmacology, efficacy, and safety of a new imidazole antifungal agent. Clin Ther. 1991;13:126-141.